These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 37502249)

  • 41. Projecting Long-term Health and Economic Burden of COPD in the United States.
    Zafari Z; Li S; Eakin MN; Bellanger M; Reed RM
    Chest; 2021 Apr; 159(4):1400-1410. PubMed ID: 33011203
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cost-Effectiveness Analysis of Non-Vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Thai Patients With Non-Valvular Atrial Fibrillation.
    Dilokthornsakul P; Nathisuwan S; Krittayaphong R; Chutinet A; Permsuwan U
    Heart Lung Circ; 2020 Mar; 29(3):390-400. PubMed ID: 31000364
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cost-Utility Analysis of Combination Empagliflozin and Standard Treatment Versus Standard Treatment Alone in Thai Heart Failure Patients with Reduced or Preserved Ejection Fraction.
    Krittayaphong R; Permsuwan U
    Am J Cardiovasc Drugs; 2022 Sep; 22(5):577-590. PubMed ID: 35796952
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The humanistic and economic burden of atopic dermatitis among adults and adolescents in Saudi Arabia.
    Elezbawy B; Fasseeh AN; Fouly E; Esba LCA; Al Abdulkarim H; Al-Haddab M; Al-Sheikh A; Altawil E; Al Turaiki A; Eshmawi M; Hamadah I; Tannira M; Dalle H; Aderian S; Roshdy A; Jaheen A; Hamad T; Abaza S; Kaló Z
    J Med Econ; 2022; 25(1):1231-1239. PubMed ID: 36426726
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Economic Burden of Rheumatoid Arthritis in Italy: Possible Consequences on Anti-Citrullinated Protein Antibody-Positive Patients.
    Mennini FS; Marcellusi A; Gitto L; Iannone F
    Clin Drug Investig; 2017 Apr; 37(4):375-386. PubMed ID: 28074337
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Health impact and economic burden of alcohol consumption in India.
    Jyani G; Prinja S; Ambekar A; Bahuguna P; Kumar R
    Int J Drug Policy; 2019 Jul; 69():34-42. PubMed ID: 31055044
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Socio-economic aspects of neurogenic dysfunctions in urology].
    Kasyan GR; Dreval RO; Krivoborodov GG; Gadzhieva ZK; Salyukov RV; Stroganov RV; Shipitsyn VV
    Urologiia; 2020 Nov; (5):127-132. PubMed ID: 33185360
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cost-effectiveness of ceftolozane/tazobactam plus metronidazole compared with piperacillin/tazobactam as empiric therapy for the treatment of complicated intra-abdominal infections based on the in-vitro surveillance of bacterial isolates in the UK.
    Prabhu V; Foo J; Ahir H; Sarpong E; Merchant S
    J Med Econ; 2017 Aug; 20(8):840-849. PubMed ID: 28532194
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Impact of rapid methicillin-resistant Staphylococcus aureus polymerase chain reaction testing on mortality and cost effectiveness in hospitalized patients with bacteraemia: a decision model.
    Brown J; Paladino JA
    Pharmacoeconomics; 2010; 28(7):567-75. PubMed ID: 20550222
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cost-effectiveness of pharmacist-participated warfarin therapy management in Thailand.
    Saokaew S; Permsuwan U; Chaiyakunapruk N; Nathisuwan S; Sukonthasarn A; Jeanpeerapong N
    Thromb Res; 2013 Oct; 132(4):437-43. PubMed ID: 24041634
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical benefits and economic cost-savings of remote electrical neuromodulation (REN) for migraine prevention.
    Cowan R; Stark-Inbar A; Rabany L; Harris D; Vizel M; Ironi A; Vieira JR; Galen M; Treppendahl C
    J Med Econ; 2023; 26(1):656-664. PubMed ID: 37083448
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cost-effectiveness analysis of pharmacogenetic-guided warfarin dosing in Thailand.
    Chong HY; Saokaew S; Dumrongprat K; Permsuwan U; Wu DB; Sritara P; Chaiyakunapruk N
    Thromb Res; 2014 Dec; 134(6):1278-84. PubMed ID: 25456732
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Carbapenem resistance, inappropriate empiric treatment and outcomes among patients hospitalized with Enterobacteriaceae urinary tract infection, pneumonia and sepsis.
    Zilberberg MD; Nathanson BH; Sulham K; Fan W; Shorr AF
    BMC Infect Dis; 2017 Apr; 17(1):279. PubMed ID: 28415969
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Exploring the economic impact of inappropriate antibiotic use: the case of upper respiratory tract infections in Ghana.
    Janssen J; Afari-Asiedu S; Monnier A; Abdulai MA; Tawiah T; Wertheim H; Baltussen R; Asante KP
    Antimicrob Resist Infect Control; 2022 Apr; 11(1):53. PubMed ID: 35365210
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The health and economic burden of smoking in 12 Latin American countries and the potential effect of increasing tobacco taxes: an economic modelling study.
    Pichon-Riviere A; Alcaraz A; Palacios A; Rodríguez B; Reynales-Shigematsu LM; Pinto M; Castillo-Riquelme M; Peña Torres E; Osorio DI; Huayanay L; Loza Munarriz C; de Miera-Juárez BS; Gallegos-Rivero V; De La Puente C; Del Pilar Navia-Bueno M; Caporale J; Roberti J; Virgilio SA; Augustovski F; Bardach A
    Lancet Glob Health; 2020 Oct; 8(10):e1282-e1294. PubMed ID: 32971051
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cost-effectiveness model of empiric doripenem compared with imipenem-cilastatin in ventilator-associated pneumonia.
    Zilberberg MD; Mody SH; Chen J; Shorr AF
    Surg Infect (Larchmt); 2010 Oct; 11(5):409-17. PubMed ID: 20666580
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The Economic Burden of Cancers Attributable to Infection in the Republic of Korea: A Prevalence-Based Study.
    Nguyen TXT; Han M; Ki M; Kim YA; Oh JK
    Int J Environ Res Public Health; 2020 Oct; 17(20):. PubMed ID: 33086534
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Estimating the Societal Benefits of THA After Accounting for Work Status and Productivity: A Markov Model Approach.
    Koenig L; Zhang Q; Austin MS; Demiralp B; Fehring TK; Feng C; Mather RC; Nguyen JT; Saavoss A; Springer BD; Yates AJ
    Clin Orthop Relat Res; 2016 Dec; 474(12):2645-2654. PubMed ID: 27699631
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Economic and Social Costs of Noma: Design and Application of an Estimation Model to Niger and Burkina Faso.
    Mpinga EK; Srour ML; Moussa MA; Dupuis M; Kagoné M; Grema MSM; Zacharie NB; Baratti-Mayer D
    Trop Med Infect Dis; 2022 Jun; 7(7):. PubMed ID: 35878131
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cost of diabetes and its complications in Thailand: a complete picture of economic burden.
    Chatterjee S; Riewpaiboon A; Piyauthakit P; Riewpaiboon W; Boupaijit K; Panpuwong N; Archavanuntagul V
    Health Soc Care Community; 2011 May; 19(3):289-98. PubMed ID: 21276105
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.